StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials total assets

Total assets on the balance sheet at the end of each period.

Regentis Biomaterials's total assets was $9.35M at Jun 30, 2026. For fiscal 2025 it was $7.62M, up 1480.5% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.62M+1480.5%
FY2024Dec 31, 2024$482.00K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.35M–
Q4 FY2025Dec 31, 2025$7.62M–
Q4 FY2024Dec 31, 2024$482.00K–

More Regentis Biomaterials figures

See a number that looks wrong?